If the market is headed toward a downturn, should you still invest?
Cortexyme said Tuesday it narrowed the pool for its Alzheimer's drug after only certain patients responded. But CRTX stock could dive.
Shares of MP Materials (NYSE: MP) plunged more than 13% by 2:45 p.m. EDT on Tuesday. Weighing on the rare earth mining company stock was a bearish report published by Grizzly Research. Grizzly Research took a swipe at MP Materials.
With the world increasingly recognizing the dire need to switch to clean energy, several economies now see electric vehicles (EVs) as a key part of their energy transition plans. You may not want to miss the race, either, so if you're looking to bet on electric vehicles, here are two top stocks you'd want to buy now. Ford (NYSE: F) is in a much stronger position now than it was roughly a year ago thanks to a leadership change.
Shares of artificial intelligence-powered fintech provider Upstart (NASDAQ: UPST) got shook up on Tuesday, down 10% as of 3 p.m. EDT after investment bank Jefferies revoked its buy rating on the stock and downgraded Upstart to hold. The analyst also worries that at present valuations -- it has a $25 billion market cap -- Upstart's stock price already "reflects strong and successful market penetration in the personal and auto loan categories over the next few years."
Yahoo Finance's Jared Blikre breaks down Robinhood's Q3 earnings report.
If you can't beat them, join them.
ViacomCBS Inc (NASDAQ: VIAC) is nearing a sale of its historic CBS Studio Center lot in Los Angeles dubbed the “Radford Lot,” the home of popular TV shows, New York Post reports. Final bids are in for the massive collection of soundstages with Hackman Capital Partners as a leading contender. Earlier this year, Hackman scooped up Sony Pictures Entertainment’s 182,000 square-foot animation campus in Culver City for around $160 million. CBS put its 38-acre campus for sale at auction in late August,
Wall Street knows it. To put that into perspective, the S&P 500's forward earnings multiple stands at 20.4. The average forward price-to-earnings ratio for pharmaceutical stocks in the index is 13.3.
These two hot semiconductor stocks have recently pulled back, but which one should investors snap up?
The graphics specialist has made a smart move to bolster its position in a potentially lucrative market.
It's been an amazing 10-year ride for Tesla investors — literally better than any other stock. The wealth created is hard to fathom.
Shares of defense industry giant Lockheed Martin (NYSE: LMT) tanked Tuesday morning, trading down by 12.1% as of 12:32 p.m. EDT even though the company reported a sizable earnings beat. Lockheed Martin's earnings plunged by 65% year over year to $2.21 per share in the third quarter -- a result that easily surpassed analysts' consensus projection for earnings of $1.97 per share. Without that charge, it would have earned nearly $7 a share and grown its earnings nearly 11% when calculated according to generally accepted accounting principles (GAAP).
Watch as Brian Sozzi, Julie Hyman, and Brian Cheung discuss how the market is reacting to the latest earnings from Twitter and AMD.
Jared Blikre, Yahoo Finance, goes in depth with the chipmaker's earnings.
A rundown of tax proposals under consideration to fund Democrats' economic package.
Visa handily beat earnings views, but guidance disappointed. Visa stock and Mastercard stock fell as Mastercard earnings loom.
Enphase Energy's earnings smashed Wall Street's estimates, with the company setting a record for sales that it expects to beat again next quarter.
Alibaba Group Holding Ltd (NYSE: BABA) founder Jack Ma has been touring Dutch research institutions to pursue his agriculture technology interests, SCMP reports. What Happened: China has a sizeable agricultural sector, where almost 40% of residents live in rural areas. China badly needs technological innovations in agriculture due to limited farmland, a shrinking rural workforce, and natural disasters. Photographers snapped Ma personally visiting several research institutes in the Netherlands fo
Shares of Novavax (NASDAQ: NVAX) have been extremely volatile as the market tries to value the company's COVID-19 vaccine. In January of last year, the company's stock was valued at $4 a share. The stock zoomed higher when COVID-19 hit, the tiny company introduced its vaccine candidate, and saw early success in clinical trials.
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...